发明名称 |
MODIFIED ERYTHROPOIETIN TO WHICH WATER-SOLUBLE LONG-CHAIN MOLECULE IS ADDED |
摘要 |
Disclosed is a pharmaceutical composition which contains erythropoietin as an active ingredient and exerts a hematopoietic effect that lasts for 7 days or more when administered to a human and/or an animal. Specifically disclosed are: a pharmaceutical composition that contains erythropoietin, to which two or more water-soluble long-chain molecules are added, in an amount of not less than 50% of the total erythropoietin; a pharmaceutical composition that contains erythropoietin to which a water-soluble long-chain molecule is added, said water-soluble long-chain molecule having a molecular weight of not less than 30 kDa; and a pharmaceutical composition that contains erythropoietin to which a water-soluble long-chain molecule is added, said water-soluble long-chain molecule having a branched chain. |
申请公布号 |
CA2773596(A1) |
申请公布日期 |
2011.03.24 |
申请号 |
CA20102773596 |
申请日期 |
2010.09.15 |
申请人 |
KANEKA CORPORATION |
发明人 |
TANI, NOBUTAKA;FUJII, TOSHIHIDE;WATANABE, HIROYUKI;MAEDA, HIROFUMI |
分类号 |
A61K38/22;A61K9/06;A61K9/08;A61K47/10;A61K47/18;A61K47/34;A61P7/06;A61P43/00 |
主分类号 |
A61K38/22 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|